Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Scheeren Joseph | Director | 5 | $126.3K | $0 | 2023-06-26 |
| Wright Robin | Director | 5 | $374.3K | $0 | 2023-05-25 |
| Morgon Pierre A. | Director | 2 | $0 | $0 | 2023-05-11 |
| Hammacher Alex | Director | 4 | $21.1K | $0 | 2023-05-11 |
| Phillips Anne M. | Director | 3 | $51.0K | $0 | 2023-05-11 |
| DAWES KAREN A | Director | 3 | $28.9K | $0 | 2023-05-11 |
| Enright William | Chief Executive Officer | 6 | $0 | $36.3K | 2023-03-27 |
| Pelletier Nadege | Chief Scientific Officer | 1 | $0 | $0 | 2023-02-01 |
| Brown Gemma | Chief Financial Officer | 2 | $0 | $0 | 2023-01-03 |
| Evans Thomas George | Fmr Chief Scientific Officer | 4 | $0 | $0 | 2023-01-03 |
| Ellis Christopher | Chief Operating Officer | 27 | $1.3K | $309.2K | 2023-01-03 |
| Marshall Margaret | Chief Medical Officer | 4 | $0 | $0 | 2023-01-03 |
| Griffiths Graham | Chief Business Officer | 18 | $1.7K | $116.1K | 2023-01-03 |
| M&G INVESTMENT MANAGEMENT LTD | 10% Owner | 2 | $1.80M | $0 | 2022-09-30 |
| M&G Alternatives Investment Management Ltd | 10% Owner | 1 | $0 | $0 | 2022-09-30 |
| Egorov Georgy | Chief Financial Officer | 3 | $0 | $0 | 2022-01-03 |
| Oxford Sciences Innovation plc | 10% Owner | 7 | $10.20M | $0 | 2021-05-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Scheeren Joseph | Director | P Buy | 2023-06-26 | 2023-06-28 | 10,000 | $2.44 | $24.4K | 23,000 | SEC↗ |
| Wright Robin | Director | P Buy | 2023-05-25 | 2023-06-01 | 13,750 | $2.66 | $36.6K | 48,256 | SEC↗ |
| DAWES KAREN A | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Hammacher Alex | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Morgon Pierre A. | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Phillips Anne M. | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Scheeren Joseph | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Wright Robin | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 19,197 | — | $0 | 19,197 | SEC↗ |
| Enright William | Chief Executive Officer | S Sale | 2023-03-27 | 2023-03-29 | 15,000 | $2.42 | $36.3K | 728,454 | SEC↗ |
| Pelletier Nadege | Chief Scientific Officer | A Award deriv | 2023-02-01 | 2023-02-24 | 485,000 | — | $0 | 485,000 | SEC↗ |
| Brown Gemma | Chief Financial Officer | A Award deriv | 2023-01-03 | 2023-02-23 | 33,100 | — | $0 | 33,100 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | A Award deriv | 2023-01-03 | 2023-02-23 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Enright William | Chief Executive Officer | A Award deriv | 2023-01-03 | 2023-02-23 | 440,000 | — | $0 | 440,000 | SEC↗ |
| Griffiths Graham | Chief Business Officer | A Award deriv | 2023-01-03 | 2023-02-23 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Evans Thomas George | Fmr Chief Scientific Officer | A Award deriv | 2023-01-03 | 2023-03-29 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Marshall Margaret | Chief Medical Officer | A Award deriv | 2023-01-03 | 2023-03-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| M&G INVESTMENT MANAGEMENT LTD | 10% Owner | J Other | 2022-09-30 | 2022-10-04 | 4,108,752 | — | $0 | 5,197,349 | SEC↗ |
| M&G Alternatives Investment Ma | 10% Owner | J Other | 2022-09-30 | 2022-10-04 | 4,108,752 | — | $0 | 0 | SEC↗ |
| Brown Gemma | Chief Financial Officer | A Award deriv | 2022-09-26 | 2022-09-28 | 334,000 | — | $0 | 334,000 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-25 | 2022-08-26 | 39,176 | — | $0 | 980 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-25 | 2022-08-26 | 14,176 | $5.69 | $80.7K | 25,075 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-25 | 2022-08-26 | 39,176 | — | $0 | 39,251 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-25 | 2022-08-26 | 25,000 | $7.07 | $176.8K | 75 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-08-25 | 2022-08-26 | 10,000 | $7.39 | $73.9K | 104,209 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-24 | 2022-08-26 | 450 | — | $0 | 40,156 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-24 | 2022-08-26 | 450 | $4.78 | $2.2K | 75 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-24 | 2022-08-26 | 450 | — | $0 | 525 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-18 | 2022-08-19 | 2,175 | — | $0 | 40,606 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-18 | 2022-08-19 | 2,175 | — | $0 | 2,250 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-18 | 2022-08-19 | 2,175 | $4.84 | $10.5K | 75 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-17 | 2022-08-19 | 649 | — | $0 | 42,781 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-08-17 | 2022-08-19 | 500 | $4.76 | $2.4K | 114,209 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-17 | 2022-08-19 | 649 | $4.77 | $3.1K | 75 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-17 | 2022-08-19 | 649 | — | $0 | 724 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-16 | 2022-08-17 | 2,200 | — | $0 | 43,430 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-08-16 | 2022-08-17 | 1,220 | $4.82 | $5.9K | 114,709 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-16 | 2022-08-17 | 2,200 | $4.78 | $10.5K | 75 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-16 | 2022-08-17 | 2,200 | — | $0 | 2,275 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-08-15 | 2022-08-17 | 5,350 | — | $0 | 45,630 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-08-15 | 2022-08-17 | 2,400 | $4.75 | $11.4K | 115,929 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-08-15 | 2022-08-17 | 5,350 | — | $0 | 5,425 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-08-15 | 2022-08-17 | 5,350 | $4.76 | $25.5K | 75 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-08-12 | 2022-08-15 | 5,000 | $4.50 | $22.5K | 118,329 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise deriv | 2022-06-28 | 2022-07-15 | 5 | — | $0 | 50,980 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | S Sale | 2022-06-28 | 2022-07-15 | 5 | $6.00 | $30 | 75 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | M Exercise | 2022-06-28 | 2022-07-15 | 5 | — | $0 | 80 | SEC↗ |
| Griffiths Graham | Chief Business Officer | L Small acq | 2022-06-24 | 2022-07-15 | 100 | $5.87 | $587 | 123,329 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise deriv | 2022-06-23 | 2022-07-15 | 2,317 | — | $0 | 2,317 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise deriv | 2022-06-23 | 2022-07-15 | 1,931 | — | $0 | 0 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise deriv | 2022-06-23 | 2022-07-15 | 3,090 | — | $0 | 6,180 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise | 2022-06-23 | 2022-07-15 | 2,317 | — | $0 | 120,147 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise | 2022-06-23 | 2022-07-15 | 3,090 | — | $0 | 123,237 | SEC↗ |
| Griffiths Graham | Chief Business Officer | S Sale | 2022-06-23 | 2022-07-15 | 8 | $5.28 | $42 | 123,229 | SEC↗ |
| Griffiths Graham | Chief Business Officer | M Exercise | 2022-06-23 | 2022-07-15 | 1,931 | — | $0 | 117,830 | SEC↗ |
| Scheeren Joseph | Director | P Buy | 2022-04-01 | 2022-04-04 | 10,000 | $5.09 | $50.9K | 13,000 | SEC↗ |
| Hammacher Alex | Director | P Buy | 2022-03-31 | 2022-04-04 | 2,000 | $5.14 | $10.3K | 3,000 | SEC↗ |
| Egorov Georgy | Chief Financial Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 114,000 | — | $0 | 114,000 | SEC↗ |
| Enright William | Chief Executive Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 359,605 | — | $0 | 359,605 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Evans Thomas George | Chief Scientific Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Griffiths Graham | Chief Business Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Marshall Margaret | Chief Medical Officer | A Award deriv | 2022-01-03 | 2022-02-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Hammacher Alex | Director | P Buy | 2021-12-31 | 2022-01-04 | 1,000 | $10.86 | $10.9K | 1,000 | SEC↗ |
| Wright Robin | Director | P Buy | 2021-12-22 | 2021-12-23 | 10,000 | $9.97 | $99.7K | 34,506 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion deriv | 2021-05-04 | 2021-05-06 | 1,704,444 | — | $0 | 0 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion deriv | 2021-05-04 | 2021-05-06 | 1,661,184 | — | $0 | 0 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion deriv | 2021-05-04 | 2021-05-06 | 4,832,142 | — | $0 | 0 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | P Buy | 2021-05-04 | 2021-05-06 | 600,000 | $17.00 | $10.20M | 8,797,770 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion | 2021-05-04 | 2021-05-06 | 1,661,184 | — | $0 | 8,197,770 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion | 2021-05-04 | 2021-05-06 | 1,704,444 | — | $0 | 6,536,586 | SEC↗ |
| Oxford Sciences Innovation plc | 10% Owner | C Conversion | 2021-05-04 | 2021-05-06 | 4,832,142 | — | $0 | 4,832,142 | SEC↗ |
| Phillips Anne M. | Director | P Buy | 2021-05-04 | 2021-05-06 | 3,000 | $17.00 | $51.0K | 3,000 | SEC↗ |
| Scheeren Joseph | Director | P Buy | 2021-05-04 | 2021-05-06 | 3,000 | $17.00 | $51.0K | 3,000 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | P Buy | 2021-05-04 | 2021-05-06 | 75 | $17.00 | $1.3K | 75 | SEC↗ |
| Wright Robin | Director | P Buy | 2021-05-04 | 2021-05-06 | 14,000 | $17.00 | $238.0K | 24,506 | SEC↗ |
| Griffiths Graham | Chief Business Officer | P Buy | 2021-05-04 | 2021-05-06 | 100 | $17.00 | $1.7K | 100 | SEC↗ |
| DAWES KAREN A | Director | P Buy | 2021-05-04 | 2021-05-06 | 1,700 | $17.00 | $28.9K | 1,700 | SEC↗ |
| Enright William | Chief Executive Officer | A Award | 2021-05-04 | 2021-05-07 | 514,923 | — | $0 | 1,258,377 | SEC↗ |
| M&G INVESTMENT MANAGEMENT LTD | 10% Owner | P Buy | 2021-04-30 | 2021-05-03 | 125,000 | $14.40 | $1.80M | 1,088,597 | SEC↗ |
| Egorov Georgy | Chief Financial Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 149,865 | — | $0 | 149,865 | SEC↗ |
| Egorov Georgy | Chief Financial Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 6,918 | — | $0 | 6,918 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 5,708 | — | $0 | 5,708 | SEC↗ |
| Ellis Christopher | Chief Operating Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 97,335 | — | $0 | 97,335 | SEC↗ |
| Evans Thomas George | Chief Scientific Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 6,942 | — | $0 | 6,942 | SEC↗ |
| Evans Thomas George | Chief Scientific Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 364,620 | — | $0 | 364,620 | SEC↗ |
| Griffiths Graham | Chief Business Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 6,054 | — | $0 | 6,054 | SEC↗ |
| Griffiths Graham | Chief Business Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 88,065 | — | $0 | 88,065 | SEC↗ |
| Marshall Margaret | Chief Medical Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 7,783 | — | $0 | 7,783 | SEC↗ |
| Marshall Margaret | Chief Medical Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 225,570 | — | $0 | 225,570 | SEC↗ |
| Enright William | Chief Executive Officer | A Award deriv | 2021-04-29 | 2021-05-04 | 176,130 | — | $0 | 176,130 | SEC↗ |
| DAWES KAREN A | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Hammacher Alex | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Morgon Pierre A. | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Phillips Anne M. | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Scheeren Joseph | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Wright Robin | Director | A Award deriv | 2021-04-29 | 2021-05-04 | 34,328 | — | $0 | 34,328 | SEC↗ |
| Enright William | Chief Executive Officer | A Award | 2021-04-29 | 2021-05-04 | 455,775 | — | $0 | 1,199,229 | SEC↗ |